Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes (ASTI)

This study has been completed.
Sponsor:
Information provided by:
Société de Formation Thérapeutique du Généraliste
ClinicalTrials.gov Identifier:
NCT00398944
First received: November 13, 2006
Last updated: July 26, 2010
Last verified: November 2006
  Purpose

The purpose is to determine wether an electronic decision support system based on national guidelines is effective to improve the follow-up and the treatment of two conditions: hypertension and diabetes, in primary care practices.


Condition Intervention
Diabetes Mellitus
Hypertension
Device: Evaluation of the impact of a guideline based computerized decision support system.

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Impact of a Computerized Decision Support System, Based on EBM French Guidelines, on the Management of Hypertension and Diabetes: a Randomised Controlled Trial in Primary Care

Resource links provided by NLM:


Further study details as provided by Société de Formation Thérapeutique du Généraliste:

Primary Outcome Measures:
  • Patients who underwent the recommended procedures during the last 12 months [ Time Frame: 16 months ] [ Designated as safety issue: No ]

Enrollment: 2715
Study Start Date: November 2006
Study Completion Date: May 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Detailed Description:

Existing computer-based ordering systems for physicians provide drug-centred checks but offer little assistance for optimizing the overall patient-centred treatment strategy.

The ASTI project aims :

  1. to design a guideline-based decision support system for diabetic and/or hypertensive patients, to help general practitioners :

    1. to carry out procedures (clinical and biological tests) according to guidelines (the recommended procedure at the recommended moment), and to get a synthetic view of all the elements they need to follow-up the patient
    2. to avoid prescription errors and to improve compliance with therapeutic guidelines. The " critic mode " operates as a background process and corrects the physician's prescription on the basis of automatically triggered elementary rules that account for isolated guideline recommendations. The " guided mode " directs the physician to the best treatment by browsing a comprehensive guideline knowledge base represented as a decision tree.
  2. To measure the impact of ASTI when it is implemented with an electronic medical record system. We adopt a randomized design, with the practice as the unit of randomization.
  Eligibility

Ages Eligible for Study:   25 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Hypertension
  • Mellitus diabetes
  • Follow-up by GP's
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00398944

Locations
France
SFTG
Paris, France, 75013
Sponsors and Collaborators
Société de Formation Thérapeutique du Généraliste
Investigators
Principal Investigator: Hector FALCOFF Société de Formation Thérapeutique du Généraliste
  More Information

Publications:
Responsible Party: Doctor Hector Falcoff, Société de Formation Thérapeutique du Généraliste
ClinicalTrials.gov Identifier: NCT00398944     History of Changes
Other Study ID Numbers: SFTG1968A
Study First Received: November 13, 2006
Last Updated: July 26, 2010
Health Authority: France: Ministry of Health

Keywords provided by Société de Formation Thérapeutique du Généraliste:
Guideline based decision support system, Hypertension, Diabetes

Additional relevant MeSH terms:
Diabetes Mellitus
Hypertension
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 26, 2014